Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.90K | 29.70K | 172.90K | 0.00 | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.90K | 29.70K | 172.90K | 0.00 | -- |
| Cost of Revenue | 205.30K | 117.30K | 155.10K | -- | -- |
| Gross Profit | -161.40K | -87.60K | 17.80K | 0.00 | -- |
| SG&A Expenses | 659.60K | 707.20K | 828.50K | 846.70K | 666.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.32M | 1.65M | 1.46M | 1.35M | 1.39M |
| Operating Income | -1.28M | -1.62M | -1.29M | -1.35M | -1.39M |
| Income Before Tax | -1.27M | -1.73M | -1.37M | -1.59M | -1.49M |
| Income Tax Expenses | -- | -- | -- | -57.70K | -- |
| Earnings from Continuing Operations | -1.27M | -1.73M | -1.37M | -1.53M | -1.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.27M | -1.73M | -1.37M | -1.53M | -1.49M |
| EBIT | -1.28M | -1.62M | -1.29M | -1.35M | -1.39M |
| EBITDA | -1.23M | -1.56M | -1.24M | -1.27M | -1.36M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 142.64M | 142.17M | 142.09M | 126.20M | 121.69M |
| Average Diluted Shares Outstanding | 142.64M | 142.17M | 142.09M | 126.20M | 121.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
